Clinical AI: Prediction Is Not a Decision
A model output can inform care, but deciding what to do requires clinical context, evidence, patient preferences and clear accountability.
#Start with the intended clinical role
A score or flag needs a defined purpose before it can be interpreted. The FDA, Health Canada and MHRA transparency principles ask for the medical purpose, intended users, use environment and target population, along with inputs, outputs and how the output is intended to affect a healthcare decision.
Read whether a tool supports a professional's judgment or is intended to replace a particular task. A prediction model, a diagnostic aid and a treatment decision are not interchangeable descriptions. An output without its intended role and known limitations leaves too much of its meaning unstated.
Evidence: FDA, Health Canada and MHRA: device transparency principles
#Evaluate the people and workflow too
IMDRF says AI-enabled devices should be assessed in their intended environment with a focus on human-AI interactions, rather than the device in isolation. Relevant considerations include users' skills, understanding of outputs and limitations, and the potential for overreliance or user error.
DECIDE-AI likewise describes interactions among a decision-support system, its users and the implementation environment as important to its clinical usefulness. A performance score from stored data does not describe every effect of placing that output into a busy care process. Read how the system and the people using it were evaluated together.
Evidence: IMDRF: good machine learning practice principles (2025) / DECIDE-AI: reporting early clinical evaluation
#Separate offline testing from live care
DECIDE-AI distinguishes offline or shadow-mode evaluation from evaluation under actual clinical conditions where supported decisions affect patient care. Early clinical studies can examine safety, human factors and practical obstacles before larger comparative evaluation. They answer a different question from retrospective predictive accuracy alone.
Ask which setting produced the evidence and what outcomes were examined. A small early evaluation is not automatically a definitive trial of patient benefit. A transparent report should make its evaluation stage clear instead of presenting every favorable result as proof of improved care.
#A checklist is not clinical permission
DECIDE-AI is reporting guidance for early-stage clinical decision-support studies. The authors explicitly say that adherence does not establish methodological quality and does not replace regulatory requirements. IMDRF principles likewise concern sound device development across the life cycle, not an endorsement of a specific product.
Use these sources to ask what evidence and limitations were reported. They do not determine an individual treatment or authorize a model's clinical use. Mynd does not operate a clinical AI service through this page, and no clinician-reviewed deployment recommendation is claimed.
Evidence: DECIDE-AI: reporting early clinical evaluation / IMDRF: good machine learning practice principles (2025)
Source note
The sections above were checked against the linked sources. No clinical review has been performed. This is general research education, not a clinical guideline.